Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Investigate the Efficacy of LT-02 in Patients With Mesalazine Refractory Ulcerative Colitis

NCT01011322 is registered in ClinicalTrials.gov with Lipid Therapeutics GmbH as lead sponsor.

NCT NCT01011322
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01011322 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Investigate the Efficacy of LT-02 in Patients With Mesalazine Refractory Ulcerative Colitis
Lead sponsor
Lipid Therapeutics GmbH
Phase
Phase 2
Overall status
Unknown status
Start date
December 31, 2009
Completion date
February 29, 2012
Enrollment
156 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal pain, diarrhea, large intestine, ulcerative colitis